Vc Thoughts, Health, Dna, Rna, Healthcare.
production systems and downstream processing will crucially determine the costs. The broader application of viral-vector-based gene therapies (for example, to more common diseases) requires higher yields and lower cost of goods (COGS). For example, during the production phase of AAVs, the size of